Respiratory system toxicity induced by immune checkpoint inhibitors: A real-world study based on the FDA adverse event reporting system database

BackgroundImmune checkpoint inhibitors (ICIs), the treatment of multiple cancer types, can be associated with respiratory system adverse events (AEs). The aim of this study is to quantify the association of respiratory system AEs and ICIs and to characterize the profiles of ICI-related respiratory s...

Popoln opis

Bibliografske podrobnosti
Main Authors: Chanjuan Cui, Lei Deng, Wenqing Wang, Xiayang Ren, Yanfeng Wang, Wei Cui
Format: Article
Jezik:English
Izdano: Frontiers Media S.A. 2022-08-01
Serija:Frontiers in Oncology
Teme:
Online dostop:https://www.frontiersin.org/articles/10.3389/fonc.2022.941079/full